Parkman Healthcare Partners LLC - Q3 2022 holdings

$352 Million is the total value of Parkman Healthcare Partners LLC's 89 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 46.1% .

 Value Shares↓ Weighting
UTHR SellUNITED THERAPEUTICS CORP DEL$17,226,000
-20.4%
82,270
-10.4%
4.90%
-38.5%
UNH SellUNITEDHEALTH GROUP INC$13,960,000
-5.7%
27,641
-4.1%
3.97%
-27.2%
DHR BuyDANAHER CORPORATION$13,691,000
+40.4%
53,006
+37.8%
3.89%
+8.4%
BSX NewBOSTON SCIENTIFIC CORP$13,470,000347,787
+100.0%
3.83%
NBIX BuyNEUROCRINE BIOSCIENCES INC$12,469,000
+49.5%
117,400
+37.2%
3.54%
+15.4%
LLY NewLILLY ELI & CO$11,409,00035,285
+100.0%
3.24%
CVS BuyCVS HEALTH CORP$11,219,000
+126.1%
117,634
+119.7%
3.19%
+74.6%
IONS BuyIONIS PHARMACEUTICALS INC$10,701,000
+65.8%
241,945
+38.8%
3.04%
+28.0%
SGEN SellSEAGEN INC$9,906,000
-26.9%
72,397
-5.5%
2.82%
-43.6%
HAE BuyHAEMONETICS CORP MASS$8,572,000
+425.9%
115,797
+363.2%
2.44%
+306.2%
THC BuyTENET HEALTHCARE CORP$8,202,000
+69.3%
159,024
+72.5%
2.33%
+30.6%
XENE SellXENON PHARMACEUTICALS INC$8,036,000
-10.3%
222,597
-24.4%
2.28%
-30.8%
ANTM SellELEVANCE HEALTH INC$7,811,000
-8.8%
17,196
-3.1%
2.22%
-29.6%
CDMO SellAVID BIOSERVICES INC$7,740,000
+10.0%
404,818
-12.2%
2.20%
-15.1%
CNCE BuyCONCERT PHARMACEUTICALS INC$7,622,000
+61.1%
1,137,587
+1.2%
2.17%
+24.3%
WAT BuyWATERS CORP$7,447,000
-14.3%
27,630
+5.3%
2.12%
-33.8%
CTIC BuyCTI BIOPHARMA CORP$7,043,000
+12.2%
1,210,145
+15.1%
2.00%
-13.4%
EW NewEDWARDS LIFESCIENCES CORP$6,768,00081,906
+100.0%
1.92%
IQV SellIQVIA HLDGS INC$6,371,000
-26.0%
35,171
-11.4%
1.81%
-42.9%
DCPH NewDECIPHERA PHARMACEUTICALS IN$5,585,000301,892
+100.0%
1.59%
BuyR1 RCM INC$5,160,000
+6.9%
278,486
+20.9%
1.47%
-17.5%
LEGN BuyLEGEND BIOTECH CORPsponsored ads$4,946,000
-23.7%
121,227
+2.9%
1.41%
-41.1%
ATEC BuyALPHATEC HLDGS INC$4,764,000
+39.1%
545,133
+4.1%
1.35%
+7.4%
NTRA BuyNATERA INC$4,610,000
+75.7%
105,201
+42.1%
1.31%
+35.7%
RYTM NewRHYTHM PHARMACEUTICALS INC$4,606,000187,989
+100.0%
1.31%
DAWN BuyDAY ONE BIOPHARMACEUTICALS I$4,250,000
+106.9%
212,191
+84.9%
1.21%
+59.8%
BuyPROCEPT BIOROBOTICS CORP$4,196,000
+35.8%
101,201
+7.1%
1.19%
+4.8%
PODD BuyINSULET CORP$3,912,000
+29.2%
17,054
+22.8%
1.11%
-0.3%
STRO BuySUTRO BIOPHARMA INC$3,815,000
+297.0%
687,335
+272.5%
1.08%
+206.5%
TMO NewTHERMO FISHER SCIENTIFIC INC$3,804,0007,500
+100.0%
1.08%
ANIP BuyANI PHARMACEUTICALS INC$3,791,000
+17.7%
117,941
+8.6%
1.08%
-9.1%
KROS BuyKEROS THERAPEUTICS INC$3,759,000
+184.8%
99,927
+109.1%
1.07%
+120.0%
ACRS SellACLARIS THERAPEUTICS INC$3,677,000
-13.6%
233,626
-23.4%
1.04%
-33.3%
BMRN NewBIOMARIN PHARMACEUTICAL INC$3,642,00042,961
+100.0%
1.04%
APEN BuyAPOLLO ENDOSURGERY INC$3,624,000
+52.7%
657,690
+1.2%
1.03%
+17.8%
RCUS SellARCUS BIOSCIENCES INC$3,607,000
-16.9%
137,894
-19.5%
1.02%
-35.9%
COGT SellCOGENT BIOSCIENCES INC$3,532,000
+35.6%
236,697
-18.0%
1.00%
+4.7%
VRNA NewVERONA PHARMA PLCsponsored ads$3,304,000323,273
+100.0%
0.94%
CTLT SellCATALENT INC$3,278,000
-54.8%
45,304
-33.0%
0.93%
-65.1%
DXCM BuyDEXCOM INC$3,250,000
+25.2%
40,358
+15.9%
0.92%
-3.3%
IRTC SellIRHYTHM TECHNOLOGIES INC$3,189,000
-60.1%
25,458
-65.6%
0.91%
-69.2%
NSTG NewNANOSTRING TECHNOLOGIES INC$3,098,000242,600
+100.0%
0.88%
SDGR BuySCHRODINGER INC$3,090,000
-4.3%
123,679
+1.2%
0.88%
-26.2%
SUPN BuySUPERNUS PHARMACEUTICALS INC$3,037,000
+18.4%
89,709
+1.2%
0.86%
-8.6%
MNKD BuyMANNKIND CORP$2,858,000
-1.9%
924,979
+20.9%
0.81%
-24.2%
BuyIMAGO BIOSCIENCES INC$2,847,000
+44.2%
189,193
+28.4%
0.81%
+11.3%
ISRG NewINTUITIVE SURGICAL INC$2,812,00015,000
+100.0%
0.80%
COO BuyCOOPER COS INC$2,803,000
-14.8%
10,622
+1.2%
0.80%
-34.2%
LNTH BuyLANTHEUS HLDGS INC$2,791,000
+97.2%
39,682
+85.2%
0.79%
+52.2%
KRTX NewKARUNA THERAPEUTICS INC$2,699,00012,000
+100.0%
0.77%
SellARCELLX INC$2,625,000
-18.4%
139,875
-21.4%
0.75%
-37.0%
AXGN BuyAXOGEN INC$2,384,000
+54.4%
200,000
+6.1%
0.68%
+19.2%
ALNY SellALNYLAM PHARMACEUTICALS INC$2,176,000
-28.0%
10,873
-47.6%
0.62%
-44.4%
IMUX BuyIMMUNIC INC$2,078,000
-7.9%
657,643
+1.2%
0.59%
-28.9%
BuyRXSIGHT INC$2,001,000
+23.6%
166,761
+45.0%
0.57%
-4.5%
ESPR NewESPERION THERAPEUTICS INC NE$1,986,000296,381
+100.0%
0.56%
FULC SellFULCRUM THERAPEUTICS INC$1,904,000
+47.9%
235,385
-10.4%
0.54%
+14.1%
AKYA SellAKOYA BIOSCIENCES INC$1,900,000
-20.0%
161,701
-12.5%
0.54%
-38.2%
BCYC BuyBICYCLE THERAPEUTICS PLCsponsored ads$1,893,000
+86.7%
81,364
+34.7%
0.54%
+44.2%
PFMT BuyPERFORMANT FINL CORP$1,893,000
-28.8%
1,023,350
+1.2%
0.54%
-45.1%
LNDC BuyLANDEC CORP$1,798,000
+48.2%
202,248
+66.3%
0.51%
+14.3%
TMDX NewTRANSMEDICS GROUP INC$1,768,00042,358
+100.0%
0.50%
XFOR NewX4 PHARMACEUTICALS INC$1,625,000950,000
+100.0%
0.46%
KNSA BuyKINIKSA PHARMACEUTICALS LTD$1,620,000
+34.1%
126,192
+1.2%
0.46%
+3.6%
KRMD BuyKORU MEDICAL SYSTEMS INC$1,524,000
-10.8%
683,466
+1.2%
0.43%
-31.2%
MDGL BuyMADRIGAL PHARMACEUTICALS INC$1,403,000
-8.1%
21,590
+1.2%
0.40%
-29.0%
LQDA NewLIQUIDIA CORPORATION$1,384,000254,452
+100.0%
0.39%
ETNB New89BIO INC$1,303,000225,000
+100.0%
0.37%
SLN BuySILENCE THERAPEUTICS PLCads$1,279,000
+311.3%
127,458
+385.6%
0.36%
+216.5%
VCYT SellVERACYTE INC$1,011,000
-31.3%
60,883
-17.7%
0.29%
-47.0%
XAIR NewBEYOND AIR INC$941,000126,442
+100.0%
0.27%
TELA BuyTELA BIO INC$940,000
+23.0%
110,280
+1.2%
0.27%
-5.0%
NewPEPGEN INC$908,000100,000
+100.0%
0.26%
ISEE NewIVERIC BIO INC$897,00050,000
+100.0%
0.26%
MIRM BuyMIRUM PHARMACEUTICALS INC$891,000
+43.0%
42,395
+32.4%
0.25%
+10.5%
ESTA NewESTABLISHMENT LABS HLDGS INC$829,00015,173
+100.0%
0.24%
OPNT BuyOPIANT PHARMACEUTICALS INC$823,000
-9.3%
76,530
+1.2%
0.23%
-29.9%
HBIO SellHARVARD BIOSCIENCE INC$782,000
-38.2%
305,353
-13.2%
0.22%
-52.4%
LXRX BuyLEXICON PHARMACEUTICALS INC$729,000
+56.8%
303,614
+21.4%
0.21%
+21.1%
VRDN NewVIRIDIAN THERAPEUTICS INC$725,00035,358
+100.0%
0.21%
TVTX BuyTRAVERE THERAPEUTICS INC$655,000
+3.0%
26,565
+1.2%
0.19%
-20.5%
CDXS SellCODEXIS INC$638,000
-70.1%
105,319
-48.4%
0.18%
-77.0%
PSTV SellPLUS THERAPEUTICS INC$590,000
-28.7%
1,325,025
-13.6%
0.17%
-44.9%
EWTX NewEDGEWISE THERAPEUTICS INC$492,00050,000
+100.0%
0.14%
TKNO BuyALPHA TEKNOVA INC$406,000
-59.7%
121,424
+1.2%
0.12%
-69.0%
STIM NewNEURONETICS INC$273,00085,866
+100.0%
0.08%
BLRX BuyBIOLINERX LTDsponsored ads$267,000
-26.8%
288,852
+1.2%
0.08%
-43.3%
SIEN SellSIENTRA INC$239,000
-31.9%
373,586
-10.9%
0.07%
-47.3%
UBX NewUNITY BIOTECHNOLOGY INC$160,000404,092
+100.0%
0.04%
SURF ExitSURFACE ONCOLOGY INC$0-115,577
-100.0%
-0.07%
EIGR ExitEIGER BIOPHARMACEUTICALS INC$0-52,733
-100.0%
-0.12%
RCKT ExitROCKET PHARMACEUTICALS INC$0-26,677
-100.0%
-0.14%
ALLK ExitALLAKOS INC$0-160,376
-100.0%
-0.18%
FMTX ExitFORMA THERAPEUTICS HLDGS INC$0-78,603
-100.0%
-0.20%
PHAT ExitPHATHOM PHARMACEUTICALS INC$0-69,135
-100.0%
-0.22%
ZYME ExitZYMEWORKS INC$0-125,806
-100.0%
-0.25%
HCAT ExitHEALTH CATALYST INC$0-63,104
-100.0%
-0.34%
MASS Exit908 DEVICES INC$0-149,315
-100.0%
-1.13%
AVTR ExitAVANTOR INC$0-172,269
-100.0%
-1.97%
ALT ExitALTIMMUNE INC$0-559,755
-100.0%
-2.41%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-11-14
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
DEXCOM INC16Q3 20236.3%
ACLARIS THERAPEUTICS INC16Q3 202310.0%
XENON PHARMACEUTICALS INC16Q3 20233.3%
NATERA INC16Q3 20233.4%
AVID BIOSERVICES INC15Q3 20232.9%
SCHRODINGER INC15Q3 20234.2%
REPRO MED SYS INC15Q2 20232.0%
MANNKIND CORP15Q3 20231.6%
IQVIA HLDGS INC14Q1 20234.6%
INSULET CORP14Q3 20232.9%

View Parkman Healthcare Partners LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Parkman Healthcare Partners LLC Q3 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
PLUS THERAPEUTICS, INC.February 13, 2023583,4671.7%

View Parkman Healthcare Partners LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-11
13F-HR2023-05-12
SC 13G/A2023-02-13
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-12
13F-HR2022-05-13
13F-HR2022-02-11

View Parkman Healthcare Partners LLC's complete filings history.

Compare quarters

Export Parkman Healthcare Partners LLC's holdings